Contraindications: BPC-157 therapy is not appropriate for patients with active cancer, during pregnancy or breastfeeding, or for those on blood thinners (anticoagulants) without provider clearance
A patient with unexplained fatigue should be worked up, not injected masking a B12 deficiency of unclear cause, or an unexamined thyroid problem, with a monthly shot is a real clinical risk
Current Urology Reports
The compound's ability to reduce fat tissue while maintaining protein mass is evidenced by body composition analyses showing that weight reduction occurs through specific targeting of adipose deposits rather than generalized tissue catabolism
is found in Vietnam, India, Thailand, Bangladesh, Indonesia, Malaysia, Cambodia, and Myanmar
Imperial Peptides UK supplies BPC-157 10mg strictly for Research Use Only, with a focus on clear documentation, traceability and responsible product information.